Breast and cervical cancer together account for more than one quarter of all female cancer deaths worldwide, with the majority – including more than 85 % of all cervical cancer deaths – occurring in developing countries. However, a small number of highly effective programs demonstrate that much can be done to reduce risk and increase sustainable access to diagnosis and treatment for these…
A young singer leans against the mixing desk in a recording studio in a laid-back manner. She listens to songs just recorded for her new album, moving her lips to the sound. Suddenly she stops, reaches for her head and seconds later collapses, unconscious. On hospital admittance physicians discover that a previously undetected aneurysm in her brain has ruptured.
Patients with atrial fibrillation, so at risk of stroke, are usually treated with medication to prevent coagulation. The Hanover Medical School (MHH) has devised an alternative treatment.
Strongly enforced legislation to restrict smoking produces rapid and substantial reductions in community rates of heart attack, according to a meta-analysis published in Circulation, the journal of the American Heart Association.
How can postoperative delirium and postoperative cognitive dysfunction be avoided? How is it best to address the problem of epilepsy? How can anaesthetists cope better with a patient death under anaesthesia? These difficult questions were among many addressed by specialists at HAI 2009, the annual conference of the German Society for Anaesthesiology and Intensive Care Medicine (DGAI). Report:…
Bettina Döbereiner continues her reports on theories, policy strategies and current projects aired in the Berlin conference Reducing Health Inequalities. What do we really know about successful strategies?
A global vaccination programme against human papilloma virus (HPV), to include boys as well as girls, could lead to eradication of the virus and virtual disappearance of cervical cancer, according to Nobel Prize winner, Professor Emeritus Harald zur Hausen (University of California, San Diego) after recently delivering a keynote lecture at the 16th International Meeting of the European Society of…
ECCO 15 – ESMO 34, the joint congress of the European CanCer Organisation (ECCO) and the European Society for Medical Oncology (ESMO), is Europe’s largest oncology meeting; the event drew to Berlin 15,000 participants from 120 countries this September, when more than 2,000 presentations were made. Among the presentations on prevention, treatment and survivorship, proteomics, biomarkers,…
Bettina Döbereiner reports on theories, policy strategies and current projects aired in the Berlin conference Reducing Health Inequalities. What do we really know about successful strategies?
As concern over the potential mutation of the latest form of influenza virus continues to vex governments and their healthcare organisations, WHO 2009 data has shown that acute respiratory infections, influenza and respiratory syncitial virus (RSV) epidemics coincide with epidemics of S. pneumoniae. In fact, half or more of flu-associated mortality in the 1918-1919 Spanish Flu epidemic is…
Philips has developed a proprietary technology for elastography that uses new strain analytics for signals captured on the IU22 volume linear transducer and yields a relative quantification of tissue stiffness, which is presented as statistical charts displayed alongside a colour-coded qualificative image superimposed on the B-mode screen.
The European Scientific Conference on Applied Infectious Disease Epidemiology (ESCAIDE) aims to strengthen and expand the network of specialists, share scientific knowledge and experience internationally, and provide a dedicated platform for EPIET/FETP (field epidemiology training programme) fellows to present their work.
At the European Society for Clinical Nutrition and Metabolism (ESPEN) congress in Vienna, experts highlighted the important relationship between nutrition and functionality in the elderly. They discussed the importance of an effective and flexible screening tool for the measurement of nutritional status, the impact of nutritional status on fall and fracture risk, and the role physical exercise…
New human papilloma virus (HPV) vaccine studies presented at the 16th International Meeting of the European Society of Gynaecological Oncology (ESGO) in Belgrade, Serbia, this week have confirmed sustained protection against precancerous cervical lesions in healthy young women, as well as beneficial effects for women previously treated for cervical, vulvar or vaginal precancers or genital warts.
Advances in cancer prevention and treatment reported at this week´s premier European congress for specialists in gynaecological cancers show that care is being more effectively tailored to the needs of individual women, so that survival can be improved without the cost of added complications and reduced quality of life.
A global vaccination programme against human papilloma virus (HPV), to include boys as well as girls, could lead to eradication of the virus and virtual disappearance of cervical cancer, predicted Nobel Prize winner, Professor Harald zur Hausen, after delivering the key-note lecture at the 16th International Meeting of the European Society of Gynaecological Oncology (ESGO) in Belgrade, Serbia,…
With respect to the sufficiently rapid utilisation of innovations, European healthcare systems are inadequately prepared for the pace of innovation that has now been reached, representatives of the European Coordination Committee of the Radiological, Electromedical and Healthcare IT Industry (COCIR) said at the European Health Forum Gastein.
The threat of communicable diseases will become even worse in the near future. At the European Health Forum Gastein, the European Union's leading health policy congress for experts and decision-makers, experts stressed that there are a number of risk factors which contribute to a growing risk of the spread of communicable diseases into Europe, namely into the European Union.
The first joint congress ECCO 15 - ESMO 34 of the European CanCer Organisation (ECCO) and the European Society for Medical Oncology (ESMO) is taking place this week in Berlin. It is the only congress in Europe that covers the entire spectrum of cancer from basic science and translational research, to prevention, treatment, nursing and supportive care for all types of tumours.
Colorectal cancer (CRC) jointly describes cancers of the colon and rectum. Worldwide, CRCs are among the most common cancers. In Europe and the USA the occurrence of CRCs are considerably higher than in Africa and Asia.
Incidence data from cancer registries have drawn the attention to colorectal cancer. It is one of the most common cancers in developed countries. In 2006, the estimated number of new cases in the European Union of 25 member states was 297,000 for both genders.
Today, transcatheter aortic valve implantation (TAVI) represents an effective therapeutic alternative to conventional aortic valve replacement for patients who are at high risk or with contraindications to surgery, and the combination of the transfemoral and transapical approaches further increases the number of patients who can be treated.
Western societies are struggling to pay for their ever increasing medical budgets. In the US up to 393 billion US-$ were spent in 2005 for cardiovascular diseases alone. Based on epidemiologic studies in primary prevention it is reasonable to estimate that 30% of coronary heart disease and stroke could be prevented by 2.5 hours of brisk walking per week.
"We have taken particular care in organising the ESC Congress, as we are aware of the stringent competition with other congresses in the light of economic difficulties" ,said Professor Roberto Ferrari, this year´s Congress President. The result is that there will be 500 hours of ESC peer sessions, over 100 hours of industry sessions, accreditation by the European Board for Accreditation in…
Measuring left ventricle ejection fraction (LVEF) is the gold standard for determining the risk of cardiac death or sudden cardiac death after a myocardial infarction (MI). If LVEF is below 30%, a cardioverter-defibrillator is implanted to avoid such an event.